Literature DB >> 19194764

Modification of blood vessel diameter following perivascular application of botulinum toxin-A.

Peter B Arnold1, Chris A Campbell, George Rodeheaver, Wyndell Merritt, Raymond F Morgan, David B Drake.   

Abstract

The purpose of this study was to demonstrate that perivascularly applied botulinum toxin-A (BTX) increases the diameter of treated blood vessels in a rat femoral vessel exposure model. Six adult Sprague-Dawley rats were used and bilateral femoral artery and vein exposures were performed. Five units of BTX were applied to the experimental side and an equal volume of sterile saline was applied to the control side. Digital images of the vessels were obtained at the following time points: pretreatment, immediately posttreatment, and postoperative days (POD) 1, 14, and 28. Vessel diameters were equivalent at baseline and immediately following application of BTX and saline. The BTX artery was significantly larger than the control artery on POD 1 and 14. The BTX treated artery was significantly larger than all other vessels on POD 14 (p < 0.05) as well as all prior time points (p < 0.01). Direct perivascular application of BTX increases the diameter of rat femoral vessels as early as POD 1. The affect is most robust on POD 14 where the artery was significantly larger than all other vessels at all time points. It is likely that the increased diameter of blood vessels results in an increased blood flow across the area of dilation. Such an increase in flow may serve to improve end-organ perfusion in microvascular procedures.

Entities:  

Year:  2009        PMID: 19194764      PMCID: PMC2724620          DOI: 10.1007/s11552-009-9169-8

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  15 in total

1.  Management of vasospastic disorders with botulinum toxin A.

Authors:  Allen L Van Beek; Paul K Lim; Andrew J L Gear; Marc R Pritzker
Journal:  Plast Reconstr Surg       Date:  2007-01       Impact factor: 4.730

Review 2.  Pharmacology of therapeutic botulinum toxin preparations.

Authors:  Dirk Dressler; Reiner Benecke
Journal:  Disabil Rehabil       Date:  2007-12-15       Impact factor: 3.033

3.  Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.

Authors:  P Schnider; M Binder; E Auff; H Kittler; T Berger; K Wolff
Journal:  Br J Dermatol       Date:  1997-04       Impact factor: 9.302

Review 4.  Botulinum and tetanus neurotoxins: structure, function and therapeutic utility.

Authors:  Kathryn Turton; John A Chaddock; K Ravi Acharya
Journal:  Trends Biochem Sci       Date:  2002-11       Impact factor: 13.807

Review 5.  The physics of pulsatile blood flow with particular reference to small vessels.

Authors:  E O Attinger
Journal:  Invest Ophthalmol       Date:  1965-12

6.  Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons.

Authors:  Judy L Morris; Phillip Jobling; Ian L Gibbins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-08-29       Impact factor: 4.733

Review 7.  Indications and efficacy of botulinum toxin in disorders of the gastrointestinal tract.

Authors:  A Mandal; R J Robinson
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 2.566

Review 8.  Review article: botulinum toxin in the therapy of gastrointestinal motility disorders.

Authors:  D Gui; S Rossi; M Runfola; S C Magalini
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

Review 9.  Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease.

Authors:  James K Sheffield; Joseph Jankovic
Journal:  Expert Rev Neurother       Date:  2007-06       Impact factor: 4.618

10.  The effects of botulinum toxin A on the survival of a random cutaneous flap.

Authors:  Taek Kyun Kim; Eun Jung Oh; Jae Young Chung; Jae Woo Park; Byung Chae Cho; Ho Yun Chung
Journal:  J Plast Reconstr Aesthet Surg       Date:  2008-04-24       Impact factor: 2.740

View more
  1 in total

1.  Autophagy gene ATG7 regulates ultraviolet radiation-induced inflammation and skin tumorigenesis.

Authors:  Lei Qiang; Ashley Sample; Christopher R Shea; Keyoumars Soltani; Kay F Macleod; Yu-Ying He
Journal:  Autophagy       Date:  2017       Impact factor: 16.016

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.